Therapeutic subgroup
N05 – PSYCHOLEPTIKA
- Anatomical main group N: NERVENSYSTEM
6Decisions
9Patient groups
Added benefit by patient group
- Minor1
- Non-quantifiable1
- Not proven7
Subgroups
- N05A ANTIPSYCHOTIKA 2 decisions
- N05C HYPNOTIKA UND SEDATIVA 4 decisions
Decisions, newest first
- 2026-06-18ByfavoRemimazolamNot proven
- 2026-06-18ByfavoRemimazolamNot proven
- 2024-08-15QuviviqDaridorexantNot proven
- 2018-10-04ReagilaCariprazinMinor: 1 of 3 patient groupsNot proven: 2 of 3 patient groups
- 2017-01-19HetliozTasimelteonNon-quantifiable
- 2015-04-16LatudaLurasidonNot proven: 2 of 2 patient groups
Data status: 2026-10-29